Never has there been a more critical time to be a company delivering technologies and expertise that helps get new biologics and vaccines to patients faster. Sartorius is that company. Working in partnership with scientists, we help turn research discoveries into real-world medicines. Our bioprocessing equipment and know-how are called on every day to create biologics that treat debilitating diseases, including cancer and arthritis, and make affordable vaccines to prevent common infections. When global organizations such as the Jenner Institute and CanSino Biologics need assistance accelerating vaccine production for pandemic viruses (e.g., Ebola, H1N1, and SARS-CoV-2), they turn to us.
Fill out the form below to read the complete capabilities review and learn more about single-use technologies for vaccine production.